U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07445984) titled 'Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)' on Feb. 13.
Brief Summary: The study will be conducted retrospectively and prospectively, using bone marrow (BM) or peripheral blood (PB) samples or biopsies of lymph nodes or tissues with metastatic involvement taken from previously stored samples here at the University Hospital of Parma or taken from patients that need to underwent diagnostic evaluation for a suspect or a defined diagnosis of hematological malignancies collected at the University Hospital of Parma.
Study Start Date: July 28, 2021
Study Type: INTERVENTIONAL
Condition:
Chronic Leukemia
Ac...